Dn B Asset Management As Acadia Pharmaceuticals Inc Transaction History
Dn B Asset Management As
- $25.3 Billion
- Q3 2025
A detailed history of Dn B Asset Management As transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Dn B Asset Management As holds 13,177 shares of ACAD stock, worth $316,511. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,177
Previous 15,611
15.59%
Holding current value
$316,511
Previous $259,000
8.49%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding ACAD
# of Institutions
374Shares Held
163MCall Options Held
1.47MPut Options Held
1.1M-
Baker Bros. Advisors LP New York, NY42.9MShares$1.03 Billion7.46% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.2MShares$365 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$290 Million0.0% of portfolio
-
State Street Corp Boston, MA7.26MShares$174 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.14MShares$172 Million2.04% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $3.89B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...